RECURSION PHARMACEUTICALS IN's ticker is RXRX and the CUSIP is 75629V104. A total of 129 filers reported holding RECURSION PHARMACEUTICALS IN in Q1 2022. The put-call ratio across all filers is 1.41 and the average weighting 1.8%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2023 | $1,336,441 | +34.7% | 200,366 | +55.7% | 0.04% | +32.1% |
Q4 2022 | $992,069 | +687.4% | 128,673 | +990.4% | 0.03% | +600.0% |
Q3 2022 | $126,000 | -71.5% | 11,800 | -78.3% | 0.00% | -80.0% |
Q2 2022 | $442,000 | +114.6% | 54,257 | +350.3% | 0.02% | +53.8% |
Q4 2021 | $206,000 | – | 12,050 | – | 0.01% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Kinnevik AB (publ) | 10,405,668 | $79,603,360 | 100.00% |
Data Collective IV GP, LLC | 5,941,120 | $45,449,568 | 43.00% |
MIC Capital Management UK LLP | 8,451,758 | $64,655,952 | 14.74% |
MV Management XI, L.L.C. | 788,762 | $6,034,029 | 10.04% |
ArchPoint Investors | 1,047,386 | $8,012,503 | 3.06% |
Connective Portfolio Management, LLC | 33,000 | $252,000 | 0.77% |
PLATINUM INVESTMENT MANAGEMENT LTD | 2,335,132 | $17,863,760 | 0.70% |
Diametric Capital, LP | 136,331 | $1,042,932 | 0.44% |
ARK Investment Management | 6,876,598 | $52,605,973 | 0.40% |
ALLEN OPERATIONS LLC | 217,657 | $1,665,076 | 0.37% |